Can older patients with stable cardiovascular disease benefit from the same cholesterol lowering drugs used by younger patients? The answer is yes, according to a study report in the July 3, 2007 issue of the Annals of Internal Medicine.
A blood component called cystatin C, used to test for early-stage kidney impairment, also may be a very early marker for those at risk of developing a condition known as pre-diabetes, a study conducted by researchers at the University at Buffalo has shown.
Squamous cell carcinoma (SCC) is a form of nonmelanoma skin cancer, which is the most common type of human malignancy with over 1 million new cases in the USA each year.
Protecting older children and adults with insecticide-treated bed nets may be an effective way to combat malaria, a study has shown. The research, published today in the open access journal PLoS Medicine, suggests that protecting half of all older children and adults would also protect the wider community from malaria, which kills over one million people each year.
An international group of fertility specialists has developed an easy-to use mathematical formula that allows a personalised approach to ovarian stimulation therapy for women seeking fertility treatment.
According to a pilot study released in the International Journal of Impotence Research (http://www.nature.com/ijir), POM Wonderful 100% Pomegranate Juice was found to have beneficial effects on erectile dysfunction (ED), a disorder that affects 1 in 10 men worldwide and 10 to 30 million men in the United States alone.
As part of The Cancer Genome Atlas (TCGA) pilot project, the National Institutes of Health (NIH) today awarded eight two-year grants totaling $3.4 million to support the development of innovative technologies for exploring the genomic underpinnings of cancer.
New findings on the mechanisms that trigger stress-induced obesity, published today in Nature Medicineonline, could offer hope to millions.
In what they call a “stunning research advance,” investigators at Georgetown University Medical Center have been able to use simple, nontoxic chemical injections to add and remove fat in targeted areas on the bodies of laboratory animals. They say the discovery, published online in Nature Medicine on July 1, could revolutionize human cosmetic and reconstructive plastic surgery and treatment of diseases associated with human obesity.
By using a new kind of genomic technology, a new study unveils a special code — not within DNA, but within the so-called “chromatin” proteins surrounding it — that could unlock the mysterious developmental choices made by mammalian cells, allowing them to assume roles as diverse as liver cells and neurons.